ArticleCancers2023

Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study.

Keiko Tanimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.